Arcutis Biotherapeutics Inc. monthly returns
Arcutis Biotherapeutics Inc. has averaged 2.86% per month, positive in 54% of months. Month-by-month returns for Arcutis Biotherapeutics Inc. (ARQT) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Arcutis Biotherapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | +9.0% | |
| Sep 2026 | +10.3% | |
| Aug 2026 | -10.8% | |
| Jul 2026 | +2.4% | |
| Jun 2026 | +22.2% | |
| May 2026 | -7.6% | |
| Apr 2026 | -1.4% | |
| Mar 2026 | -12.6% | |
| Feb 2026 | +6.3% | |
| Jan 2026 | -12.6% | |
| Dec 2025 | -5.3% | |
| Nov 2025 | +21.1% | |
| Oct 2025 | +34.3% | |
| Sep 2025 | +21.5% | |
| Aug 2025 | +6.4% | |
| Jul 2025 | +4.0% | |
| Jun 2025 | +7.5% | |
| May 2025 | -12.5% | |
| Apr 2025 | -4.7% | |
| Mar 2025 | +14.2% | |
| Feb 2025 | +3.4% | |
| Jan 2025 | -5.0% | |
| Dec 2024 | +6.8% | |
| Nov 2024 | +56.9% | |
| Oct 2024 | -10.6% | |
| Sep 2024 | -14.5% | |
| Aug 2024 | +8.0% | |
| Jul 2024 | +8.3% | |
| Jun 2024 | +11.2% | |
| May 2024 | +0.5% | |
| Apr 2024 | -16.0% | |
| Mar 2024 | -3.6% | |
| Feb 2024 | +75.1% | |
| Jan 2024 | +81.7% | |
| Dec 2023 | +75.5% | |
| Nov 2023 | -18.2% | |
| Oct 2023 | -57.6% | |
| Sep 2023 | -37.8% | |
| Aug 2023 | -21.7% | |
| Jul 2023 | +14.5% | |
| Jun 2023 | +26.9% | |
| May 2023 | -45.7% | |
| Apr 2023 | +25.8% | |
| Mar 2023 | -32.0% | |
| Feb 2023 | -2.4% | |
| Jan 2023 | +12.0% | |
| Dec 2022 | -14.1% | |
| Nov 2022 | -2.5% | |
| Oct 2022 | -7.5% | |
| Sep 2022 | -29.1% | |
| Aug 2022 | +11.1% | |
| Jul 2022 | +13.8% | |
| Jun 2022 | +2.1% | |
| May 2022 | +3.4% | |
| Apr 2022 | +4.8% | |
| Mar 2022 | +8.2% | |
| Feb 2022 | +17.8% | |
| Jan 2022 | -27.1% | |
| Dec 2021 | +25.2% | |
| Nov 2021 | -21.8% | |
| Oct 2021 | -11.3% | |
| Sep 2021 | +12.8% | |
| Aug 2021 | -9.3% | |
| Jul 2021 | -14.5% | |
| Jun 2021 | +3.6% | |
| May 2021 | -21.3% | |
| Apr 2021 | +15.8% | |
| Mar 2021 | -15.3% | |
| Feb 2021 | +25.2% | |
| Jan 2021 | -3.0% | |
| Dec 2020 | +3.7% | |
| Nov 2020 | +52.2% | |
| Oct 2020 | -39.2% | |
| Sep 2020 | +16.9% | |
| Aug 2020 | -6.1% | |
| Jul 2020 | -11.7% | |
| Jun 2020 | -9.9% | |
| May 2020 | +12.9% | |
| Apr 2020 | -0.3% | |
| Mar 2020 | +12.1% | |
| Feb 2020 | +21.9% |
Monthly total return (since Nov 2021)#
Arcutis Biotherapeutics Inc. returns by calendar month#
Every month of every year since 2021, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: +9.04% — 2nd of 6 Octobers since 2021 at the last close; the average October returned -10.6%.
| Month | −85%0+85% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +7.7% | -4.0% | 33% | +81.7% 2024 | -27.1% 2022 | |
| Feb | +20.9% | +12.1% | 83% | +75.1% 2024 | -2.4% 2023 | |
| Mar | -6.9% | -8.1% | 33% | +14.2% 2025 | -32.0% 2023 | |
| Apr | +4.0% | +1.7% | 50% | +25.8% 2023 | -16.0% 2024 | |
| May | -13.9% | -10.1% | 33% | +3.4% 2022 | -45.7% 2023 | |
| Jun | +12.2% | +9.4% | 100% | +26.9% 2023 | +2.1% 2022 | |
| Jul | +4.8% | +6.1% | 83% | +14.5% 2023 | -14.5% 2021 | |
| Aug | -2.7% | -1.4% | 50% | +11.1% 2022 | -21.7% 2023 | |
| Sep | -6.1% | -2.1% | 50% | +21.5% 2025 | -37.8% 2023 | |
| Oct | -10.6% | -10.6% | 20% | +34.3% 2025 | -57.6% 2023 | |
| Nov | +7.1% | -2.5% | 40% | +56.9% 2024 | -21.8% 2021 | |
| Dec | +17.6% | +6.8% | 60% | +75.5% 2023 | -14.1% 2022 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from ARQT's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Arcutis Biotherapeutics Inc.'s average monthly return?
- Arcutis Biotherapeutics Inc. (ARQT) has averaged about 2.86% per month, positive in roughly 54% of months. The best month was Jan 2024 (+81.7%) and the worst was Oct 2023 (-57.6%).